Page 9 - Kathleen Bloch News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CytoSorbents Announces Health Canada Regulatory Approval For Pivotal STAR-T Trial

/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.

United statesRichard whitlockEfthymiosn deliargyrisKathleen blochMaterial commandEuropean unionUs armyBlood instituteCytosorbents corporationNational heartNational institutes of healthHuman servicesUs department of healthPopulation health research instituteUs airCanada research

CytoSorbents Appoints Irina B Kulinets, PhD, as Senior Vice President of Global Regulatory Affairs

/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.

United statesSouth koreaGeorgetown universityDistrict of columbiaNortheastern universityIrina kulinetsIrinab kulinetsVincent capponiKathleen blochMaterial commandClinical researchCytosorbents corporationRegulatory affairs professionals societyAnika therapeuticsRegulatory affairsNational institutes of health

CytoSorbents Receives $5M in Non-Dilutive Debt Financing from Bridge Bank and Extends Loan Agreement

/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.

United statesKathleenp blochKathleen blochMaterial commandSecurity bankEuropean unionAlliance bancorporationUs armyBlood instituteCytosorbents corporationNational heartNational institutes of healthHuman servicesUs department of healthAlliance bankUs air

CytoSorbents Receives Recommendation from Independent Data and Safety Monitoring Board to Continue Pivotal STAR-T Trial As Planned Without Modifications

/PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac.

United statesEfthymiosn deliargyrisKathleen blochUs department of healthHuman servicesMaterial commandNational institutes of healthUs airEuropean unionUs armyHealth canadaBlood instituteCytosorbents corporationNational heartSorbents corporationSafety monitoring board

Cytosorbents (CTSO) Announces DSMB s Recommendation to Continue STAR-T Trial As Planned Without Modifications

Cytosorbents (CTSO) Announces DSMB s Recommendation to Continue STAR-T Trial As Planned Without Modifications
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesEfthymiosn deliargyrisKathleen blochUs department of healthHuman servicesMaterial commandNational institutes of healthUs airEuropean unionUs armyHealth canadaBlood instituteCytosorbents corporationNational heartSorbents corporationSafety monitoring board